Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older, of any gender
- People who have been diagnosed with a type of irregular heartbeat called atrial fibrillation (AF) — either the kind that comes and goes (paroxysmal) or the kind that persists over time (persistent)
- People who are already scheduled to have a catheter ablation procedure at Tulane University Medical Center
- People whose doctor has already ordered a cardiac MRI as part of their normal medical care
Who may not be able to join:
- People who have a blood clotting disorder, such as von Willebrand disease, hemophilia, or Immune Thrombocytopenic Purpura (ITP), among others
- People who are pregnant, breastfeeding, or planning to become pregnant during the study period
- People who are not surgically sterile and are able to have children but are unwilling to use two accepted methods of birth control during the trial (confirm with trial site for which methods qualify)
- People who have a physical or mental health condition that might prevent them from fully participating in the study
- People who have any medical reason they cannot safely have an MRI or receive gadolinium contrast dye — for example, a known allergy to gadolinium, or certain implanted devices such as a pacemaker or defibrillator
- People who have been diagnosed with a terminal illness and have a life expectancy of less than 12 months at the time of joining the study
- People who have a planned heart or blood vessel procedure scheduled
- People who have been diagnosed with severe kidney disease, or whose kidney filtration rate (a measure of how well the kidneys work) is below 30 mL/min/1.73m²
- People who cannot read, speak, or understand English
- People who have a cognitive impairment that prevents them from giving informed consent to participate
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Amitabh Pandey, MD, Tulane University
Phone: 504-988-3063
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Measure the change in Asymmetric dimethyl arginine (ADMA) in relation to atrial fibrillation burden; Measure the change in markers of platelet activation P-selectin and Platelet factor 4 in relation to atrial fibrillation burden; Measure the change in B-thromboglobulin in relation to atrial fibrillation burden; Measure the change in coagulation marker Von Willebrand factor in relation to atrial fibrillation burden; Measure the change in Thrombin Antithrombin levels in relation to atrial fibrillation burden; Measure the change in Prothrombin time (PT) in relation to atrial fibrillation burden;...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.